ABSTRACT: Sarcoplasmic reticulum (SR) Ca 2ϩ release has been shown not to be the predominant mechanism responsible for excitation-contraction (E-C) coupling in fetal myocytes. However, most of the studies have been conducted either on primary cultures or acutely isolated cells, in which an apparent reduction of ryanodine receptor density have been reported. We aimed to elucidate the contribution of SR Ca 2ϩ release and Ca 2ϩ transporters on sarcolemmal channels to Ca 2ϩ transients in fetal mouse whole hearts. On embryonic day 13.5, ryanodine significantly reduced the amplitude of the Ca 2ϩ transient to 27.2 Ϯ 4.4% of the control, and both nickel and SEA0400 significantly prolonged the time to peak from 84 Ϯ 2 ms to 140 Ϯ 5 ms and 129 Ϯ 6 ms, respectively, whereas nifedipine did not alter it. Therefore, at early fetal stages, SR Ca 2ϩ release should be an important component of E-C coupling, and T-type Ca 2ϩ channel and reverse mode sodium-calcium exchanger (NCX)-mediated SR Ca 2ϩ release could be the predominant contributors. Using embryonic mouse cultured cardiomyocytes, we showed that both nifedipine and nickel inhibited the ability of NCX to extrude Ca 2ϩ from the cytosol. From these results, we propose a novel idea concerning E-C coupling in immature heart. (Pediatr Res 69: 306-311, 2011)
M yocardial remodeling plays important roles in the development of heart failure and arrhythmogenesis after myocardial infarction. During cardiac remodeling, the expressions of fetal genes such as those for the T-type Ca 2ϩ channel (TCC) (1,2) and sodium-calcium exchanger (NCX) (3) (4) (5) are up-regulated, and the resultant T-type Ca 2ϩ currents are thought to be involved in the pathological process that leads to systolic dysfunction and arrhythmogenesis (6, 7) . In the fetal heart, however, the roles played by Ca 2ϩ transporters remain unclear. In adult hearts, excitation-contraction (E-C) coupling is initiated by a rapid increase in the myoplasmic Ca 2ϩ concentration, generated mainly by Ca 2ϩ release from the sarcoplasmic reticulum (SR). This SR Ca 2ϩ flux is mediated by the opening of ryanodine receptors (RyRs) in response to a small trigger Ca 2ϩ stimulus [Ca 2ϩ -induced Ca 2ϩ release; calciuminduced calcium release (CICR)], which is provided by the voltage-dependent Ca 2ϩ channels [L-type Ca 2ϩ channels (LCCs)] located in the sarcolemma (8) .
In isolated ventricular myocytes obtained from fetuses or newborns, RyR-mediated CICR has been reported to provide only a small amount of Ca 2ϩ influx (9 -12) . According to a previous study on neonatal whole hearts, a sarcolemmal Ca 2ϩ influx via TCCs and reverse mode NCXs is predominantly responsible for the rapid increase in the cytosolic Ca 2ϩ concentration (13) (14) (15) .
However, most of the studies have been conducted either on primary cultures or acutely isolated cells and an apparent reduction of RyR density (16) and alterations in cell shape (13) have been reported. Previously, we used fetal mouse whole heart models to examine the effect of a SR Ca 2ϩ ATPase inhibitor on this Ca 2ϩ transient and indicated that Ca 2ϩ reuptake from the SR might be functional even on embryonic day (ED) 12.5 (17) . We hypothesized that Ca 2ϩ release from the SR might be responsible for the increase in intracellular Ca 2ϩ concentration even in fetal hearts and that Ca 2ϩ transporters such as TCCs and NCXs might be involved in cardiac contraction in such hearts. In this study, we concluded that during the developmental changes 1) RyR plays an important role in CICR, 2) TCC and reverse mode NCX are more effective than LCC as a trigger for CICR, and 3) nifedipine and nickel may not only inhibit Ca 2ϩ channels but also inhibit NCX.
METHODS
The study was performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (National Institutes of Health Publication No. 85-23, revised 1996), and the protocols were approved by the Institute Animal Research Committee of the National Defense Medical College.
Experiment 1
Whole heart preparation and fluorescence measurements. Fetal mouse whole hearts at ED 10.5, 13.5, and 16.5 were obtained as previously reported (17) . Briefly, the hearts were stained by immersion in a 20 M solution of the Ca 2ϩ -sensitive fluorescent indicator Fluo-3 AM (Molecular Probes, Eugene, OR) for 15 min at 37°C. After loading, the heart was transferred to a chamber on a microscope (OLYMPUS IX-70) and then washed out at 37°C with control solution (18) 
Experiment 2
Ventricular myocytes: isolation and cultures. Ventricular myocytes were enzymatically isolated from fetal mouse hearts (24, 25) . Fetal mice at ED 14.5 were taken out, and the hearts were quickly removed. Only the ventricles were minced into 0.5-1.0 mm 3 pieces. There were added to 0.03% trypsin ϩ 0.03% collagenase in saline (total 10 mL), put into a trypsinizing flask, stirred as a trypsin step, and the top layer transferred to another tube with culture medium. After repeating the trypsin step four times, the myocytes were spun in a centrifugal separator at 200 ϫ g for 10 min. Sedimented myocytes were scattered by pippeting in Ham F-12 (Life Technologies Japan, Tokyo) ϩ Medium 199 (Life Technologies Japan, Tokyo) ϩ penicillin-streptomycin (total 10 mL) containing 10% FCS, passed through a filter, and put on eight 25-mm diameter glass coverstrips in a 100-mm diameter dish. After addition of adequate medium, they were cultured in a CO 2 incubator at 37°C for 2 d.
Caffeine-induced Ca 2؉ transients. Caffeine-induced Ca 2ϩ transients (26, 27) in fetal self-beating ventricular myocytes were recorded using the photomultiplier described above. Caffeine releases Ca 2ϩ from the SR (28) and elimination of intracellular Ca 2ϩ is attributed to NCX. The analysis of the time course of the decay of the caffeine-induced Ca 2ϩ transient allows evaluation of the functions of forward-mode NCX and sarcolemmal calcium pump, when nifedipine or nickel is present. We used four protocols in which solutions were applied sequentially as follows (Fig. 1 pump ( Fig. 2A) . In protocol 2, after incubation in a solution containing caffeine and normal Na ϩ , intracellular Ca 2ϩ is rapidly extruded mainly via NCX (Fig. 2B ). In protocol 3, myocytes were incubated in a solution containing zero Ca 2ϩ and zero Na ϩ plus either nifedipine or nickel, followed by a solution containing caffeine, normal Na ϩ , and either nifedipine or nickel ( Fig. 2C and D) . This allowed us to examine the effects of these Ca 2ϩ -channel blockers on NCX. In protocol 4, a solution containing caffeine, zero Na ϩ , and either nifedipine or nickel was used. This allowed us to examine the effects of these blockers on the sarcolemmal Ca 2ϩ pump. In these protocols, we measured the 
RESULTS

Experiment 1
Effects of Ca 2؉ -channel blockers on the amplitude of the Ca 2؉ transient in fetal mouse whole hearts. In ED 13.5 mouse whole hearts, the amplitude of the Ca 2ϩ transient was reduced by 72.8 Ϯ 4.2%, 34.4 Ϯ 4.2%, 26.5 Ϯ 4.2%, and 16.7 Ϯ 6.6% on ryanodine, nifedipine, nickel, and SEA0400 application, respectively (p Ͻ 0.01, p Ͻ 0.01, p Ͻ 0.01, and p Ͻ 0.05, respectively; Fig. 3 ). The inhibition ratio was significantly greater upon ryanodine application than upon nifedipine, nickel, or SEA0400 application (p Ͻ 0.01; Fig. 3E ). In both of ED 10.5 and 16.5 mouse whole hearts, the inhibition ratio upon ryanodine application was also significantly greater than that upon the other sarcolemmal Ca 2ϩ channels blocker application (data not shown).
Effects of Ca
2؉ -channel blockers on TTP and T 50 values for Ca 2؉ transients in fetal mouse whole hearts. There was no significant difference of TTP between before and after application of nifedipine, while there was a significant prolongation with both nickel and SEA0400 at all embryonic stages (p Ͻ 0.01; Table 1 ). At ED 10.5, the prolongation of TTP was significantly greater with nickel than with SEA0400 (p Ͻ 0.05). The prolongation ratio of the TTP upon nickel application was significantly greater on ED 10.5 than on ED 16.5 (p Ͻ 0.05; Fig. 4A ), but no such difference was detected for SEA0400 (Fig. 4B) .
Unexpectedly, the T 50 value of the Ca 2ϩ transient value was significantly greater after application of nifedipine, nickel, and SEA0400 than in control at all embryonic stages [p Ͻ 0.01, except for nifedipine on ED 13.5 (p Ͻ 0.05); Table 1 ]. 
Experiment 2
Effects of Ca
2؉ -channel blockers on caffeine-induced Ca 2؉ transient in fetal mouse cultured myocytes. To elucidate the effects of nifedipine and nickel, which has been often used as LCC and TCC blockers, respectively, on the sarcolemmal Ca 2ϩ pump and NCX, we measured the T 50 value of the caffeine-induced Ca 2ϩ transient using fetal mouse cultured myocytes (Figs. 1 and 2) . NCX function kept intact in the final solution containing Na ϩ on the protocol 2, 3-1, and 3-2. As a result, the amplitude of caffeine-induced Ca 2ϩ transients on these protocols were smaller than that on protocol 1, because Ca 2ϩ was continuously extruded via NCX as SR released Ca 2ϩ after caffeine application. There was no significant difference of the amplitude of caffeine-induced Ca 2ϩ transients between protocol 2 and 3 (data not shown). Therefore, to investigate the effect of nifedipine and nickel on NCX function, we evaluated T 50 of caffeine transients of protocol 3, compared with protocol 2.
The T 50 value of the caffeine-induced Ca 2ϩ transient in zero-Na ϩ solution was 5.24 Ϯ 0.37 s (n ϭ 5), whereas in normal Na ϩ solution, it was 1.08 Ϯ 0.15 s (n ϭ 9; Fig. 2A , B, and E). The T 50 values of the caffeine-induced Ca 2ϩ transient in solutions containing normal Na ϩ ϩ nifedipine and normal Na ϩ ϩ nickel were 2.38 Ϯ 0.10 s (n ϭ 3) and 3.86 Ϯ 0.17 s (n ϭ 10), respectively (Fig. 2C, D, and E) . T 50 values on protocol 3-1 and 3-2 were significantly larger than that on protocol 2. In protocol 4, the T 50 values were not significantly different versus protocol 1 (data not shown), indicating that neither nifedipine nor nickel had any influence on the sarcolemmal Ca 2ϩ pump.
DISCUSSION
In this article, three new contributions are presented. First, during the developmental changes, RyR plays an important role in CICR even at the early embryonic stage. Second, TCC and reverse-mode NCX were each more effective than LCC as a trigger for CICR at the sarcolemmal Ca 2ϩ -channel level in fetal cardiomyocytes. Third, nifedipine and nickel may not only inhibit Ca 2ϩ channels but also NCX on the basis of data obtained in mouse cultured cardiomyocytes.
Contribution of SR Ca 2؉ release, LCC, TCC, and reverse mode NCX to the Ca 2؉ transient. The reduction in the amplitude of the Ca 2ϩ transient upon application of ryanodine to the fetal mouse heart at ED 13.5 was about 73%, whereas the reductions seen with blockers of LCC, TCC, and reverse mode NCX were only 34, 27, and 17%, respectively, indicating that SR Ca 2ϩ release may be functional and be the major contributor to E-C coupling even at early fetal stages. This is the first study to demonstrate the importance of SR Ca 2ϩ release in mouse whole hearts at early fetal stages. Our data are similar to those obtained in two previous studies. Using fetal rat isolated cardiomyocytes, Seki et al. (29) reported an 84% reduction in the amplitude of the Ca 2ϩ transient upon application of ryanodine. Using d 1 rat whole hearts, Ostádalová et al. (30) found a Ͼ50% reduction in contraction upon application of ryanodine. In contrast, Escobar et al. (13) reported that ryanodine reduced the amplitude of the Ca 2ϩ transient only 10% on d 1 and of 32% on d 5, using rat neonatal whole hearts stimulated at 2 Hz. The discrepancy may derive from the use of different stimulation frequencies (0.5 Hz versus 2 Hz) (31,32), a species difference, or an age difference.
It is well known that the SR is both at lower density and immature at fetal and neonatal stages (33) . However, a recent report demonstrated that RyR densities were reduced in cell culture, indicating that SR function might be underestimated in culture (16) . Moreover, intrinsic cardiac adrenergic (ICA) cells play an important role in fetal heart development (34). These cells, which exist before sympathetic innervation, are capable of catecholamine synthesis, release, uptake, and generate spontaneous Ca In a preliminary study, we found that upon high-dose nickel (500 M) application, the amplitude of the Ca 2ϩ transient was greatly reduced, and its TTP was greatly prolonged. These results are consistent with both TCC and reverse-mode NCX being inhibited by high-dose nickel, as indicated by a previous study (13) . Accordingly, we used low-dose (100 M) nickel to make separate evaluations of TCC from NCX.
In this study on fetal mouse whole hearts, the TTP of the Ca 2ϩ transient became significantly longer after application of nickel or SEA0400, indicating that TCC and reverse-mode NCX possibly contribute to sarcolemmal calcium entry as triggers of CICR. This speculation may be supported by the up-regulations of TCC and reverse mode NCX mRNAs reported in fetal and neonatal cardiomyocytes (22, (35) (36) (37) , and by the opening of TCC at more negative membrane potentials than LCC. Furthermore, the prolongation of TTP at ED 10.5 was significantly greater with nickel than with SEA0400. TCC expression was reported to be greatest in chick ventricles at early embryonic stages (ED 5) (20) . It has been reported that TCC blockers prolonged the TTP of the Ca 2ϩ transient more effectively than LCC blockers in rat neonatal whole hearts (13) . Although a previous report claimed that the distance between the sarcolemmal LCCs and SR Ca 2ϩ -release channels needed to be short (38) , our results may raise the possibility that colocalization with RyR in tighter for TCCs than for LCCs at early fetal stages. To resolve this issue, further investigations concerning TCC function as a trigger of CICR will be necessary.
Effects of Ca 2؉ -channel blockers on cardiac diastolic phase in fetal mouse cultured myocytes. Using the fetal mouse cultured myocytes, we found that 1) application of nifedipine or nickel partially inhibited the extrusion of Ca 2ϩ from the cytosol via NCX and 2) the NCX-inhibitory effect of nickel was greater than that of nifedipine. That is, at fetal stages, nifedipine and nickel have influences over NCX function in the diastolic phase of the Ca 2ϩ transients, while nifedipine has been widely used as LCC blocker and nickel as NCX and/or TCC blocker. To the best of our knowledge, this is the first report that nifedipine has an inhibitory effect on forward-mode NCX rates. Because the mRNA levels for the sarcolemmal NCX reach peak near birth in developing hearts (37) , it would be important to study the pharmacological effects on NCX in developing hearts furthermore.
There are several limitations of this study. First, we could not investigate the effects of action potential (AP) configuration in our stimulated whole hearts, although the amplitude of Ca 2ϩ transient has been shown to be exquisitely sensitive to changes in AP configuration in immature myocardium (39, 40) . It has been reported that the shortened AP result in less time for NCX-mediated Ca 2ϩ influx and thereby reduce the amplitude of Ca 2ϩ transient (40) . As the major source of Ca 2ϩ influx in neonatal mytocyte is through the NCX (41,42), Ca 2ϩ homeostasis in immature hearts should be largely affected by AP configuration. Nevertheless, the lack of these considerations should not change our conclusions that were reached by relative comparisons in whole hearts stimulated electrically by same frequency and pulse duration.
Second, the agents used to dissect the various calcium transport pathways were not entirely selective. There is a possibility that they might have some effects on other transporters, because we did not demonstrate the presence of each Ca 2ϩ channel current. However, low concentration nickel has been reported to useful to investigate TCC function in previous articles (20 -22) , although higher concentration nickel has often be used to inhibit NCX activity (19) . SEA0400 also has been reported to be more selective inhibitor of the reverse mode NCX than the previously used agents like KB-R7943 (23) . Therefore, we believe that the lack of current data would not make our conclusions feeble.
Third, it has recently been reported that there is an important role for IP 3 R-gated calcium stores in contributing to calcium transients and contraction in neonatal rat myocytes. Primary subsarcolemmal IP 3 -mediated Ca 2ϩ release was shown to be capable of activating local RyRs to produce a secondary CICR and was suppressed in the presence of ryanodine (43) . Therefore, the lack of the selective inhibition to IP 3 -mediated Ca 2ϩ release in our study would not change our conclusions for the important role of RyR in CICR, although we should investigate the role of IP 3 R on CICR in fetal hearts in future.
In conclusion, on the basis of our results, we propose the following a novel ideas: 1) SR Ca 2ϩ release may be the major contributor to E-C coupling even in the fetal mouse heart, 2) TCC and reverse-mode NCX functions may contribute more than LCCs to CICR in the fetal mouse heart, and 3) nifedipine and nickel inhibit not only Ca 2ϩ entry through Ca 2ϩ channels but also Ca 2ϩ extrusion through NCX in the fetal mouse heart. We believe that the present results may not only contribute to the medication rationale for fetal and neonatal heart failure but also be a useful contribution to the discussion of the medication target for adult heart failure, because the shifts in sarcolemmal Ca 2ϩ channels occurring during early embryonic stages can be regarded as a reflection of the changes that take place in adult heart failure.
